USR Barcelona

RESPONSABLE
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Publicaciones

The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients

A. SIERRA, S. OTERO, E. RODRIGUEZ, A. FAURA, M. VERA, M. RIERA, V. PALAU, X. DURAN, A. COSTA-GARRIDO, L. SANS, E. MARQUEZ, V. POPOSKI, J. FRANCH-NADAL, X. MUNDET, A. OLIVERAS, M. CRESPO, J. PASCUAL and C. BARRIOS
Journal of Clinical Medicine. 2022 Mar 1; . doi:10.3390/jcm11051431; PMID:35268522

Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population

A. CEBRIAN-CUENCA, M. MATA-CASES, J. FRANCH-NADAL, D. MAURICIO, D. OROZCO-BELTRAN and L. CONSUEGRA-SANCHEZ
European Journal of Preventive Cardiology. 2022 Feb 9; . doi:10.1093/eurjpc/zwaa073; PMID:33733654

Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care

E. FERNANDEZ-LIZ, P. VIVO-TRISTANTE, A. ARANZANA-MARTINEZ, M. BARCELO-COLOMER, M. LARROSA-GARCIA, J. GARCIA and E. MARTIN-GRACIA
CURRENT MEDICAL RESEARCH AND OPINION. 2021 Apr 3; . doi:10.1080/03007995.2021.1885366; PMID:33538192

  • Any: 03/04/2021
  • FI: 2.705
  • Article

Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database

J. FRANCH-NADAL, J. REAL, M. MATA-CASES, E. ORTEGA, J. VALLES, B. VLACHO and D. MAURICIO
Endocrinologia Diabetes y Nutricion. 2022 Feb 1; . doi:10.1016/j.endinu.2021.01.013; PMID:34088634

Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care

C. LLOR, A. MORAGAS, C. BAYONA, J. COTS, S. HERNANDEZ, O. CALVINO, M. RODRIGUEZ and M. MIRAVITLLES
CLINICAL MICROBIOLOGY AND INFECTION. 2022 Feb 1; . doi:10.1016/j.cmi.2021.07.035; PMID:34363942